MENU
LYEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lyell Immunopharma (LYEL) Ownership - Who owns Lyell Immunopharma?
Lyell Immunopharma Inc is a clinical-stage cell therapy company... Show more
Profile
Industry
N/A
Address
201 Haskins Way
Phone
+1 650 695-0677
Employees
224
Web
https://www.lyell.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
252.24M
P/E Ratio
N/A
Total Cash
276.79M
Projected Growth
N/A
Total Debt
46.6M
Revenue
60K
Risk (Beta)
1.02
Dividend Yield
N/A
Total Cash/Share
14.41
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
LYEL
Capitalization
252M
P/E Ratio
N/A
Risk (Beta)
1.02
Dividend Yield
N/A
Total Cash
277M
Total Cash/Share
14.41
Total Debt
46.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
60K
ROE
N/A
Book Value
299M
P/B Ratio
0.85
Cash Flow
N/A
Earnings
-24.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
7.65
Current Revenue Per Employee
26.67
Dividends Per Share - Security
N/A
EBITDA
-199.95M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-63.76
Shares Held By Institutions
87.8M
Shares Outstanding - Current
19.2M
Total Liabilities
86.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
3.281
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
201 Haskins Way
Phone
+1 650 695-0677
Employees
224
Web
https://www.lyell.com